The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Coming back to: Sample size calculations, read backwards from the published number

This is a generated summary. It shows the 9 most-liked posts from a topic of 89, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
N
NardoneTL2Member27 Mar 2025#6

I read post #4 twice before replying, because I had assumed the opposite.

Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between them tells you how many people benefit.

26 likes 16mo
YR
y.rahimiTL228 Apr 2025#18
preregistered, post #15: Where I part company with post #11, and it is a narrow parting. Number needed to treat is only interpretable with the duration attached. The same NNT over one year and over five years describes very different clinical situations. Go to post

A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened had everyone continued. Both are legitimate and they give different numbers.

Adding the caveat now so it does not have to be extracted later.

30 likes in reply to #15 15mo
BI
blank_injectionTL2Analytical chemist26 May 2025#31

Understood. Thank you for being specific about the limits of it.

25 likes 14mo
JD
j.dahlbergTL214 Jun 2025#40

Noted, and thank you for writing it out rather than summarising it.

24 likes 13mo
DY
d.yilmazTL216 Jun 2025#41
y.rahimi, post #18: A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened had everyone continued. Both are legitimate and they give different numbers. Adding the caveat now so it does not have to be extracted later. Go to post

An update on my earlier Sample size calculations post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.

33 likes in reply to #18 13mo
NN
n.nybergTL223 Jun 2025#45

Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment), concealment (could randomisation be subverted), blinding (who was blinded and why or why not), completeness of outcome reporting.

24 likes 13mo
C
chromatogramTL4Analytical chemist12 Jul 2025#55

I would be cautious about generalising from the Sample size calculations example above. It is a good example. It is one example.

31 likes 13mo
DM
d.moreauTL2Regular28 Jul 2025#64

Practical answer on Sample size calculations, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated explanation is needed. It usually is not.

25 likes 12mo
HH
h.hutchingsTL1Member30 Aug 2025#83
f.ibarra, post #79: Sample size calculations sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly. Go to post

Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between them tells you how many people benefit.

25 likes in reply to #79 11mo

Read the full topic (89 posts)

Promoted into the documentation commons. The content of this topic is maintained at Retatrutide phase 2 (obesity) — trial digest, with named maintainers and a review date. The promotion was discussed in doc review. Corrections are best raised against the document, which is the version that gets kept current.

Suggested topics

TopicParticipantsRepliesViewsActivity
[2026 update] Reading a supplementary appendix and finding the interesting part
On the subject in the title: Reading a supplementary appendix and finding the interesting part Working notes rather than a conclusion. Collecting what is known about Reading a supplementary appendix in one…
KFIDFIOCH+39 44 8.2k 5mo
How to read a forest plot, properly, from scratch
The question in the title: How to read a forest plot, properly, from scratch I will give what I have already checked below so nobody repeats it. Reading STEP 4 ( JAMA , 2021) for the population rather than…
SCPDBJRMYM+73 81 17k 7mo
Follow-up: What a statistical analysis plan adds that the paper does not
What a statistical analysis plan adds that the paper does not I have a specific reason for asking rather than idle curiosity, and the context is below. A follow-up question about statistical analysis plan…
SBEMTT 2 7.2k 3mo
Composite endpoints and the component doing the work
Composite endpoints and the component doing the work Writing it up because I had to work it out twice and would rather nobody else did. Collecting what is known about composite endpoints in one place, because…
RVIDSSVKFP+3 7 33k 13h
Interim analyses and stopping rules — does this still hold?
Interim analyses and stopping rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Interim analyses and stopping rules, from the point of view…
JDMHKMFTHL+30 34 29k 13mo

Related topics — sharing the tags estimand, discontinuation & dropout, surrogate endpoints

TopicParticipantsRepliesViewsActivity
Second pass at: Reading a combination trial: attributing effect to components
Second pass at: Reading a combination trial: attributing effect to components — setting out what I have, and where I think it stops being reliable. The question about Reading a combination trial that I…
ELPBLCMNBP+39 43 7.3k 12mo
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset
Posting this under the heading it deserves: Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Everything below is what sits behind that. Posting a small dataset on STEP 8. It is…
OLIADSRFDO+18 22 656 13h
[2026 update] Journal club: FLOW and the renal composite, component by component
Journal club: FLOW and the renal composite, component by component Writing it up because I had to work it out twice and would rather nobody else did. A question about what the numbers mean rather than what…
NBTAC 2 21k 9d
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset
Posting this under the heading it deserves: Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Everything below is what sits behind that. Posting a small dataset on SURMOUNT-4 and…
VMLADNWMD+58 64 17k 13mo
Primary endpoint hierarchies and why order matters
Primary endpoint hierarchies and why order matters Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about primary endpoint hierarchies in a thread last spring and…
LCDSFWCLNK 4 308 3mo